Detalhe da pesquisa
1.
Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial.
Melanoma Res
; 34(2): 142-151, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092013
2.
Pembrolizumab-Induced Thyroiditis Shows PD-L1Expressing Histiocytes and Infiltrating T Cells in Thyroid Tissue - A Case Report.
Front Immunol
; 12: 606056, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34220792
3.
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.
J Immunother Cancer
; 9(2)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33608376